Journal of Psychoactive Drugs / 2026
This retrospective study examines how age and cannabis co-use relate to acute psilocybin experiences, perceived benefits, and substance co-use patterns.
JAMA Psychiatry / 2025
This review synthesizes emerging data on psilocybin use trends, product variability, co-use with other substances, and adverse event reports. It highlights parallels with the cannabis legalization trajectory, showing that potency, product diversity, and unsupervised use are increasing while regulation and public education lag behind.
Frontiers in Psychology Sec. Consciousness Research / 2025
This study refines and validates the Psychedelic Aesthetic Experience Questionnaire, a tool designed to measure the aesthetic qualities of psychedelic experiences.
Neuropsychologia / 2025
This paper outlines neural mechanisms underlying the aesthetic experience during psychedelic states and calls for direct research.
Frontiers in Psychology Sec. Consciousness Research / 2025
This study links the aesthetic quality of retrospective self-reported psychedelic experiences to measures of perceived insight and psychological outcomes.
Frontiers in Psychiatry / 2025
This randomized pilot trial evaluates the safety, tolerability and clinical effects of hemp-derived cannabidiol in individuals with alcohol use disorder.